Which ICD-10-CM code should be used to document vitamin B12 deficiency without anemia for ongoing monthly intramuscular cyanocobalamin therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Code for Vitamin B12 Deficiency Without Anemia

For ongoing monthly intramuscular cyanocobalamin therapy in a patient with vitamin B12 deficiency but no anemia present, use ICD-10-CM code E53.8 (Deficiency of other specified B group vitamins).

The provided evidence focuses primarily on clinical treatment guidelines for vitamin B12 deficiency rather than specific ICD-10 coding guidance. However, based on standard ICD-10-CM coding principles and the clinical context:

Coding Algorithm

When anemia is NOT present:

  • E53.8 - Deficiency of other specified B group vitamins (includes vitamin B12 deficiency without anemia)

When anemia IS present:

  • D51.x codes - Vitamin B12 deficiency anemia (the code you should NOT use in this case)
    • D51.0 - Vitamin B12 deficiency anemia due to intrinsic factor deficiency
    • D51.3 - Other dietary vitamin B12 deficiency anemia
    • D51.8 - Other vitamin B12 deficiency anemias
    • D51.9 - Vitamin B12 deficiency anemia, unspecified

Critical Distinction

The D51 series specifically requires the presence of anemia 1. Research confirms that the positive predictive value for D51 coding when anemia is actually present ranges from only 31.5% to 36.8%, indicating this code is frequently misused 1. Do not use D51.x codes when documenting vitamin B12 deficiency without anemia, as this represents inaccurate coding that can affect reimbursement and data quality.

Clinical Context for Ongoing Therapy

The guidelines support that patients with vitamin B12 deficiency without neurological involvement should receive maintenance treatment with 1 mg intramuscularly every 2-3 months for life after initial loading doses 2. This maintenance therapy justifies continued use of the E53.8 code even after initial correction of laboratory values, as lifelong supplementation is medically necessary.

Common Coding Pitfall

Avoid coding based solely on treatment received. The fact that a patient receives intramuscular B12 does not automatically mean they have anemia. Code based on the actual clinical presentation: vitamin B12 deficiency (E53.8) versus vitamin B12 deficiency anemia (D51.x).

Related Questions

What is the next step in managing a patient with suspected vitamin B12 deficiency who has already received parenteral cyanocobalamin injections?
Which ICD‑10‑CM code should be used for a patient receiving monthly intramuscular cyanocobalamin for vitamin B12 deficiency anemia, and what additional code is appropriate if the deficiency is due to intrinsic factor deficiency?
Which routine laboratory tests (complete blood count, coagulation profile, serum protein panel, lipid profile, electrolytes, and vitamin B12) should be ordered to diagnose deficient intestinal absorption syndrome, why each is important, what abnormalities are expected, and how these findings aid in establishing the diagnosis?
What is the optimal treatment strategy for a 24-year-old female with a serum vitamin B12 level of 218 pg/mL?
Is a 1500 µg (1.5 mg) intramuscular dose of hydroxocobalamin appropriate for treating vitamin B12 deficiency?
What are the mechanisms of action and therapeutic uses of amantadine?
Which ICD‑10‑CM code should be used for a patient receiving monthly intramuscular cyanocobalamin for vitamin B12 deficiency anemia, and what additional code is appropriate if the deficiency is due to intrinsic factor deficiency?
Is a D-dimer result of 0.19 µg/mL FEU considered negative?
Can I take three doses of ibuprofen while taking Eliquis (apixaban)?
What are the effects and considerations of using Viibryd (vilazodone) in patients with alpha‑1 antitrypsin deficiency?
What is the significance of a 4 mm plantar‑surface signal abnormality at the second metatarsal head seen only on an axial T2‑weighted MRI, and what management is recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.